A note before this piece. What's covered next reflects our current understanding of advertising rules affecting clinics, drawn from secondary summaries of the relevant regulations. It has not yet been checked against the primary source (the ASA's CAP Code and the Human Medicines Regulations 2012) by a compliance specialist. Therefore, please treat it as a starting point for a conversation with your own compliance adviser, not as a final answer. Where a point below is stated with less certainty, that's deliberate, not an oversight.
Most clinic websites either say too much or say almost nothing at all, out of a vague sense that the rules are strict. Understanding what's genuinely restricted, and what isn't, means a site can be both compliant and useful, which is written into how we approach beauty and aesthetics websites more broadly.
Contents
The core restriction
Prescription-only medicines cannot be advertised to the public at all, and enforcement treats almost any reference, direct or indirect, as likely to breach that rule. This extends beyond the medicines most people immediately think of, to brand names of prescription dermal fillers containing certain anaesthetic ingredients too. The safe, compliant approach is to use generic descriptions instead of any brand name, "anti-wrinkle injections" instead of a specific product name, for example. Even softer phrasing intended to imply the same thing without naming it, such as describing a treatment as "wrinkle-relaxing", can still be treated as an implied reference.
This is the part that catches out clinics genuinely trying to be careful. Dropping the brand name while keeping every other detail that makes the treatment obviously identifiable doesn't reliably solve the problem, which is exactly the kind of judgement call worth checking with a compliance specialist instead of assuming from this summary alone.
Before-and-after images and pricing
Before-and-after images count as implied advertising where they make it clear that a prescription-only procedure was performed, even without naming anything directly, because the visual result itself is doing the advertising. Publishing prices for treatments that fall into this category tends to have the same effect, since a price attached to a visible result functions as an advertisement whether or not any medicine is named. The safer path is educational content that doesn't rely on showing, or pricing, the restricted treatment itself.
Where content marketing legitimately fits
Educational content about how a consultation works, or about how facial anatomy changes over time, is not advertising a medicine. This is exactly where genuinely useful content marketing earns its place on a clinic site. A page explaining what happens during a consultation, what questions get asked and what a practitioner is assessing, builds real trust without straying anywhere near the restricted territory around a specific treatment.
This is also, in practice, the content that tends to perform best in search, since it answers the questions a nervous first-time patient is typing into Google, such as 'what does a consultation involve?', 'what should I expect?' or 'how do I know if I'm suitable?' - none of which require naming or pricing anything restricted to answer honestly and in useful depth.
Two smaller but consistent complaint triggers
Inconsistent lighting or camera angles between a before photo and an after photo is a common trigger for complaints, since it can make a result look more dramatic than it was in reality, regardless of if this was intended. Also, permanent 'special offers' breach separate consumer protection rules around genuine, time-limited promotions - so anything presented as a limited-time offer needs to be genuinely limited, not a permanent fixture masquerading as urgency.
Influencer posts
If a clinic works with influencers, those posts need proper advertising disclosure, clearly and unambiguously stated, not a hidden hashtag buried at the end of a caption. This applies whether a payment changed hands directly or if the arrangement was a free treatment in exchange for a post.
Enforcement is active
This is not a theoretical risk. Regulatory enforcement in this area has been active, with reporting on AI-driven monitoring specifically targeting this kind of content. Treating this as a low-priority compliance area because enforcement feels distant is not a safe assumption to make.
What to do instead
None of this means a clinic has to go quiet about what it offers. It means being precise: generic descriptions instead of brand names, educational content instead of results-focused advertising for restricted treatments. It also needs honest and consistent before-and-after presentation where images are used for treatments that are permitted to be advertised, as well as genuine urgency in any offer - not manufactured urgency. This is exactly the kind of constraint a compliant clinic site has to be built around from the outset, not retrofitted once the copy is already written. Where you're unsure whether specific copy crosses a line, that's a conversation worth having with the ASA directly or with a compliance specialist before publishing, not a guess worth taking a chance on.
